UASt regulatory sequences drive expression of an inverted repeat.
Adults expressing Aats-alaGD8009 under the control of the cardioblast-specific Scer\GAL4tin.CΔ4 driver show significantly reduced survival on day 6 after a shift to 29[o]C compared to control flies.
Adults expressing Aats-alaGD8009 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of Aats-alaGD8009 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies or partial lethality, depending on the particular P{GD8009} insertion line used.
Expression under the control of Scer\GAL4Mef2.PR results in late larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in grossly normal larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.
Expression under the control of Scer\GAL4pnr-MD237 results in lethality (either before or at the pupal stage), depending on the insertion line used.
AlaRSGD8009, Scer\GAL4GMR.PFa is a suppressor | partially of visible | adult stage phenotype of Scer\GAL4GMR.PFa, ykiS168A.UAS.EGFP,Tag:HA
AlaRSGD8009, Scer\GAL4GMR.PFa is a suppressor | partially of neoplasia | adult stage phenotype of Scer\GAL4GMR.PFa, ykiS168A.UAS.EGFP,Tag:HA
AlaRSGD8009, Scer\GAL4GMR.PFa is a suppressor | partially of eye phenotype of Scer\GAL4GMR.PFa, ykiS168A.UAS.EGFP,Tag:HA